OPTIMIZERX CORP (OPRX) Stock News
NASDAQ:OPRX - Nasdaq - US68401U2042 - Common Stock - Currency: USD
OPRX Latest News, Press Relases and Analysis
There are notable gap-ups and gap-downs in today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Which stocks are moving before the opening bell on Tuesday?
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
DSGX's Solution Used by ArrowXL to Boost Last Mile Delivery
Descartes announces that ArrowXL is leveraging its cloud-based route planning and execution solution to streamline last mile delivery operations.
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?
OptimizeRx (OPRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...
US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of 172.73% and 15.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MGIC
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to...
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
Microsoft (MSFT) Q3 Earnings and Revenues Beat Estimates
Microsoft (MSFT) delivered earnings and revenue surprises of 8.13% and 2.46%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MSFT
Cadence Design Systems (CDNS) Beats Q1 Earnings and Revenue Estimates
Cadence (CDNS) delivered earnings and revenue surprises of 5.37% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CDNS
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company...
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
No Stockholder Action Required at this Time
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
No Stockholder Action Required at this Time...
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team...
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...